Fortis Healthcare Ltd Analyst Rating
based on 14 analysts
93.33%
Buy
0.00%
Hold
6.67%
Sell
Based on 14 analysts offering long term price targets for Fortis Healthcare Ltd. An average target of ₹706.21
Source: S&P Global Market Intelligence
Fortis Healthcare Ltd Share analysis
Fortis Healthcare Ltd price forecast by 14 analysts
Upside of9.57%
High
₹787
Target
₹706.21
Low
₹550
Fortis Healthcare Ltd target price ₹706.21, a slight upside of 9.57% compared to current price of ₹644.5. According to 14 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Fortis Healthcare Ltd revenue growth forecast
Expected growth rate Q1, FY2027:41.95%
Forecast
Actual
Including amortisation and stock based compensations
Fortis Healthcare Ltd EPS growth forecast
EPS estimate Q1, FY2027:116.14%
Forecast
Actual
Source: S&P Global Market Intelligence
Fortis Healthcare Ltd Performance
Day's Low
Day's High
₹641.05Day's Price Range₹664.852 Week's Low
52 Week's High
₹163.4252-Week Price Range₹744.5
| Returns % | |
| 1 Month Return | -5.6 % |
| 3 Month Return | + 5.73 % |
| 1 Year Return | + 53.02 % |
| Market Stats | |
| Previous Close | ₹663.40 |
| Open | ₹664.80 |
| Volume | 10.18L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹50,083.92Cr |
Fortis Healthcare Ltd Key Statistics
| P/E Ratio | 74.17 |
| PEG Ratio | 51.86 |
| Market Cap | ₹50,083.92 Cr |
| P/B Ratio | 3.49 |
| EPS | 8.55 |
| Dividend Yield | 0.24 |
| Sector | Healthcare |
| ROE | 1.37 |
Fortis Healthcare Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹50,083.92 Cr | 70.05% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
| BUY | ₹1,02,069.00 Cr | 163.74% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
| BUY | ₹97,624.75 Cr | 63.8% | 0.65 | ₹917 Cr | ₹19,059 Cr | |
| BUY | ₹26,774.33 Cr | 51.37% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| BUY | ₹24,518.51 Cr | 41.11% | 0.58 | ₹336 Cr | ₹2,498 Cr |
Fortis Healthcare Ltd Mutual Fund Holdings
About Fortis Healthcare Ltd
Fortis Healthcare Ltd. is well known for its top products, such as medical equipment, pharmaceuticals, diagnostics, and medical devices. It also has a wide range of popular brands, such as Fortis Health, Fortis Care, and Fortis Plus.
Share Price: ₹644.50 per share as on 17 Jan, 2025 04:01 PM
Market Capitalisation: ₹50,083.92Cr as of today
Revenue: ₹1,988.39Cr as on September 2024 (Q3 24)
Net Profit: ₹193.08Cr as on September 2024 (Q3 24)
Listing date: 09 May, 2007
Chairperson Name: Ravi Rajagopal
| Organisation | Fortis Healthcare Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Fortis Healthcare Ltd
Allegations of Fund Siphoning at Fortis Healthcare - 18 Jan, 2025
Fortis Healthcare faces allegations of siphoning Rs 472 crore, with the Singh brothers implicated. In 2019, Fortis sought legal action against them to recover dues.Fortis Healthcare Acquires Majority Stake in Agilus - 17 Jan, 2025
On January 17, 2025, Fortis Healthcare announced the completion of its acquisition of a 31.52% stake in Agilus Diagnostics, raising its ownership to 89.2%. JM Financial also predicts a high likelihood of Fortis being included in the MSCI Standard Index.Fortis Healthcare Sees Strong Stock Performance and New Initiatives - 14 Jan, 2025
Fortis Healthcare's stock has rallied 178% since May 2023, with expected inflows of $176 million from MSCI index addition. The company also launched an emergency helpline campaign in Mumbai.Fortis Healthcare Shows Strong Investment Potential - 01 Jan, 2025
Fortis Healthcare presents a compelling investment case, driven by impressive revenue growth, improved occupancy rates, and strategic expansions. Leadership in cardiac and oncology therapies, along with rising insurance penetration in India, is expected to sustain strong demand for its services.Fortis Healthcare Experiences Volatile Trading Days - 31 Dec, 2024
Fortis Healthcare stock rose 3.07% on December 30, outperforming its sector. However, it declined 3.38% on December 31, despite a positive monthly performance.Fortis Healthcare Hits All-Time High with Strong Gains - 30 Dec, 2024
On December 30, 2024, Fortis Healthcare achieved an all-time high, gaining 8.09% over two days and outperforming its sector. The stock has delivered a remarkable annual return of 74.91%, significantly exceeding the Sensex's performance.Brokerage Firm Initiates Buy Rating on Fortis Healthcare - 28 Dec, 2024
A brokerage firm has initiated a Buy rating on Fortis Healthcare, citing strong revenue growth and solid financial performance. The firm highlights the hospital chain's specialization in key therapies, predicting sustained demand. Investors are advised to add the stock to their portfolios with a target price of Rs 860 per share.Leo Puri Appointed Chairman of Fortis Healthcare - 27 Dec, 2024
Fortis Healthcare Ltd has appointed Leo Puri as Chairman of its Board of Directors, effective December 27, 2024. Puri, an experienced leader, will guide the company's strategic direction and operations. His appointment follows the interim chairmanship of Indrajit Banerjee, who will remain on the board. The company reported a 4.99% increase in net profit for Q2 FY25.Fortis Healthcare Reports Growth in ARPOB - 25 Dec, 2024
Fortis Healthcare reported growth in Average Revenue Per Occupied Bed (ARPOB) for 2024, driven by a favorable case mix and increased patient volumes in high-revenue specialties like oncology and neurosciences. The company attributes this growth to expanded bed capacity, advanced medical infrastructure, and a revival in international medical tourism post-COVID-19.Fortis Healthcare Expands Stake in Agilus Diagnostics - 20 Dec, 2024
Fortis Healthcare has acquired a 7.61% stake in Agilus Diagnostics from IFC for ₹429.37 crore, as part of a broader plan to acquire 31.52% equity in Agilus. The acquisition is expected to enhance Fortis's market position in diagnostics.
Insights on Fortis Healthcare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, FORTIS stock has moved up by 10.9%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 23.31% to 25.26% in Sep 2024 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, FORTIS has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 1.69K Cr → 2.00K Cr (in ₹), with an average increase of 5.4% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 165.96 Cr → 176.46 Cr (in ₹), with an average increase of 6.0% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 31.17% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 173.0% return, outperforming this stock by 41.6%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 13.21% to 12.84% in Sep 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 27.52% to 27.23% in Sep 2024 quarter
Fortis Healthcare Ltd Financials
Index Inclusions
Fortis Healthcare Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 31.17% | 0.00 | |
| Foreign Institutions | 25.26% | 8.38 | |
| Mutual Funds | 27.23% | ||
| Retail Investors | 12.84% | ||
| Others | 3.51% |
Fortis Healthcare Ltd Key Indicators
Fortis Healthcare Ltd Valuation
Fortis Healthcare Ltd in the last 5 years
Lowest (-166.21x)
June 25, 2021
Today (74.17x)
January 17, 2025
Industry (97.73x)
January 17, 2025
Highest (165.13x)
April 9, 2020
Fortis Healthcare Ltd Earnings and Dividends
Fortis Healthcare Ltd Earnings Results
Fortis Healthcare Ltd’s net profit jumped 1.58% since last year same period to ₹176.46Cr in the Q2 2024-2025. On a quarterly growth basis, Fortis Healthcare Ltd has generated 6.33% jump in its net profits since last 3-months.
Read More about Earnings ResultsFortis Healthcare Ltd Dividends May,2024
In the quarter ending March 2024, Fortis Healthcare Ltd has declared dividend of ₹1 - translating a dividend yield of 0.31%.
Read More about Dividends
Fortis Healthcare Ltd Technicals Summary
Bearish
Neutral
Bullish
Fortis Healthcare Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Fortis Healthcare Ltd
Fortis Healthcare Ltd share price today stands at ₹644.5, Open. ₹664.8 ; Previous Close. ₹663.4 ; High. ₹664.8 ; Low. ₹641.05 ; 52 Week High. ₹744.5 ; 52 Week Low: ₹163.42.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Fortis Healthcare Ltd shares.
Fortis Healthcare Ltd is listed on NSE
Fortis Healthcare Ltd is listed on BSE
- Today’s highest price of Fortis Healthcare Ltd is ₹664.8.
- Today’s lowest price of Fortis Healthcare Ltd is ₹641.05.
PE Ratio of Fortis Healthcare Ltd is 74.17
PE ratio = Fortis Healthcare Ltd Market price per share / Fortis Healthcare Ltd Earnings per share
Today’s traded volume of Fortis Healthcare Ltd(FORTIS) is 10.18L.
Today’s market capitalisation of Fortis Healthcare Ltd(FORTIS) is ₹50083.92Cr.
| Fortis Healthcare Ltd(FORTIS | Price |
|---|---|
52 Week High | ₹744.5 |
52 Week Low | ₹163.42 |
Fortis Healthcare Ltd(FORTIS) share price is ₹644.5. It is down -13.43% from its 52 Week High price of ₹744.5
Fortis Healthcare Ltd(FORTIS) share price is ₹644.5. It is up 294.38% from its 52 Week Low price of ₹163.42
| Fortis Healthcare Ltd(FORTIS | Returns |
|---|---|
1 Day Returns | -18.9% |
1 Month Returns | -5.6% |
3 Month Returns | 5.73% |
1 Year Returns | 53.02% |